IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $520,839 | -26.1% | 114,470 | +14.3% | 0.00% | -25.0% |
| Q2 2023 | $704,957 | +58.5% | 100,136 | +37.6% | 0.00% | +33.3% |
| Q1 2023 | $444,637 | -2.4% | 72,772 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $455,754 | -33.6% | 71,323 | -0.4% | 0.00% | -40.0% |
| Q3 2022 | $686,000 | -11.9% | 71,583 | +1.4% | 0.01% | 0.0% |
| Q2 2022 | $779,000 | +2334.4% | 70,572 | +3528.4% | 0.01% | – |
| Q1 2022 | $32,000 | -15.8% | 1,945 | -1.5% | 0.00% | – |
| Q4 2021 | $38,000 | -24.0% | 1,974 | -2.3% | 0.00% | – |
| Q3 2021 | $50,000 | -12.3% | 2,021 | -8.0% | 0.00% | – |
| Q2 2021 | $57,000 | -41.8% | 2,196 | -28.9% | 0.00% | – |
| Q1 2021 | $98,000 | -38.8% | 3,090 | -10.7% | 0.00% | -100.0% |
| Q4 2020 | $160,000 | +34.5% | 3,459 | -4.0% | 0.00% | 0.0% |
| Q3 2020 | $119,000 | +16.7% | 3,604 | -2.6% | 0.00% | – |
| Q2 2020 | $102,000 | -95.1% | 3,700 | -94.7% | 0.00% | -100.0% |
| Q1 2020 | $2,076,000 | +2.2% | 69,362 | -5.5% | 0.01% | +37.5% |
| Q4 2019 | $2,031,000 | +54.1% | 73,368 | +1.3% | 0.01% | +60.0% |
| Q3 2019 | $1,318,000 | -26.3% | 72,415 | -0.7% | 0.01% | -28.6% |
| Q2 2019 | $1,788,000 | +178.5% | 72,919 | +8.0% | 0.01% | +250.0% |
| Q1 2019 | $642,000 | +4.1% | 67,515 | -3.1% | 0.00% | -33.3% |
| Q4 2018 | $617,000 | +0.7% | 69,703 | +27.9% | 0.00% | +50.0% |
| Q3 2018 | $613,000 | -10.5% | 54,513 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $685,000 | -13.9% | 53,531 | +13.6% | 0.00% | -33.3% |
| Q1 2018 | $796,000 | +139.8% | 47,114 | +13.6% | 0.00% | +200.0% |
| Q4 2017 | $332,000 | +20.7% | 41,470 | +17.0% | 0.00% | 0.0% |
| Q3 2017 | $275,000 | +14.1% | 35,431 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $241,000 | – | 32,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |